Search bioRxiv⌕ Search

Biology subjects

Smeriglio, R.

Publications and source records attributed to Smeriglio, R..

3 recordsLinked to original sources

Start&Stop - a PhysiCell and PhysiBoSS 2.0 add-on for interactive simulation control

In computational biology, in silico simulators are vital for exploring and understanding the behavior of complex biological systems. Hybrid multi-level simulators, such as PhysiCell and PhysiBoSS 2.0, integrate multiple layers of biological complexity, providing deeper insights into emergent patterns. However, one key limitation of these simulators is the inability to adjust simulation parameters once the simulation has started, which hinders the interactive exploration and adaptation of dynamic protocols ranging from biofabrication to in vitro pharmacological testing. To address this challenge, we introduce the Start & Stop add-on for PhysiCell and PhysiBoSS 2.0. This add-on offers multi-level state preservation and multi-modal stop control, triggered by simulation time or cell conditions, enabling users to pause a simulation, adjust parameters, and then resume from the exact halted state. We validate Start & Stop using two well-established PhysiBoSS 2.0 use cases, a tumor spheroid 3T3 mouse fibroblasts use case under tumor necrosis factor (TNF) stimulation, and a lung cancer cell line invasion simulation, demonstrating that it preserves the simulators original behavior while enabling interactive configuration changes that facilitate the exploration of diverse and adaptive treatment strategies. By enhancing flexibility and user interaction, Start & Stop makes PhysiCell and PhysiBoSS 2.0 more akin to real in vitro scenarios, thus expanding the range of potential simulations and advancing more effective protocol development in a variety of applications.

bioinformatics↗

Leveraging protein-protein interactions in phenotype prediction through graph neural networks

Current genotype-to-phenotype models, such as poly-genic risk scores, only account for linear relationships between genotype and phenotype and ignore epistatic interactions, limiting the complexity of the diseases that can be properly characterized. Protein-protein interaction networks have the potential to improve the performance of the models. Moreover, interactions at the protein level can have profound implications in understanding the genetic etiology of diseases and, in turn, for drug development. In this article, we propose a novel approach for phenotype prediction based on graph neural networks (GNNs) that naturally incorporates existing protein interaction networks into the model. As a result, our approach can naturally discover relevant epistatic interactions. We assess the potential of this approach using simulations and comparing it to linear and other non-linear approaches. We also study the performance of the proposed GNN-based methods in predicting Alzheimers disease, one of the most complex neurodegenerative diseases, where our GNN approach outperform state of the art methods. In addition, we show that our proposal is able to discover critical interactions in the Alzheimers disease. Our findings highlight the potential of GNNs in predicting phenotypes and discovering the underlying mechanisms of complex diseases.

genetics↗

Fast and Accurate LSTM Meta-modeling of TNF-induced Tumor Resistance In Vitro

Multi-level, hybrid models and simulations, among other methods, are essential to enable predictions and hypothesis generation in systems biology research. However, the computational complexity of these models poses a bottleneck, limiting the applicability of methodologies relying on large number of simulations, such as the Optimization via Simulation (OvS) of complex biological processes. Meta-models based on approximate surrogate models simplify multi-level simulations, maintaining accuracy while reducing computational costs. Among Artificial Neural Networks (ANNs), Long Short-Term Memory (LSTM) networks are well suited to handle sequential data, which often characterizes biological simulations. This paper presents an LSTM-based surrogate modeling approach for multi-level simulations of complex biological processes. Validation relies on the simulation of Tumor Necrosis Factor (TNF) administration to a 3T3 mouse fibroblasts tumor spheroid based on PhysiBoSS 2.0, a hybrid agent-based multi-level modeling framework. Results show that the proposed LSTM meta-model is accurate and fast compared with the simulator. In fact, it infers simulated behavior with an average relative error of 7.5%. Moreover, it is at least five orders of magnitude faster. Even considering the cost of training, this approach provides a faster, more accurate, and reusable surrogate of multi-scale simulations in computationally complex tasks, such as model-based OvS of biological processes.

bioinformatics↗